Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Kilty Cormac G
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+3,600$450→ 10,800 total - Exercise/Conversion
Restricted Share Units
2017-07-01−3,600→ 0 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying)
Holdings
- 144,364
Ordinary Shares
Footnotes (2)
- [F1]Shares are held jointly with spouse.
- [F2]3,600 of the Restricted Share Units vested and became convertible on 7/1/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting.